FDA NDC Directory · JSON-LD · Markdown

RETEVMO

NDC 0002-3977 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameselpercatinib
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA213246
Dosage form / routeCAPSULE · ORAL
Active ingredientsSELPERCATINIB (40 mg/1)
Marketing started20200508
Package count1

External sources

Source: openFDA. Public-domain (CC0).